Panacea Innovation Ltd
SEC Form 4 insider trading activity
Panacea Innovation Ltd has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: May 11, 2026.
On the most recent filing, Panacea Innovation Ltd is listed as 10% Owner at Atara Biotherapeutics, Inc. Inside the rolling window, Panacea Innovation Ltd reported no open-market purchases and 2 open-market sales totaling $3.7M in ATRA. The largest disclosed transaction in the window is a sale of 313,446 ATRA shares on May 7, 2026, worth $3.2M.
Companies traded
Other insiders at ATRA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Panacea Innovation Ltd made?
Panacea Innovation Ltd has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Panacea Innovation Ltd trade?
Panacea Innovation Ltd has filed SEC Form 4 disclosures for 1 company, including ATRA.
When was Panacea Innovation Ltd's most recent SEC Form 4 filing?
Panacea Innovation Ltd's most recent SEC Form 4 filing on Tracefour is dated May 11, 2026.
What is Panacea Innovation Ltd's total buy and sell value in the current window?
Inside the rolling retention window, Panacea Innovation Ltd bought $0 and sold $3.7M based on SEC Form 4 filings.
What was Panacea Innovation Ltd's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 313,446 ATRA shares on 2026-05-07, worth $3.2M, per SEC Form 4 filings.